Hedera Group AB (publ)
STO:HEGR
Relative Value
There is not enough data to reliably calculate the relative value of HEGR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
HEGR Competitors Multiples
Hedera Group AB (publ) Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
H
|
Hedera Group AB (publ)
STO:HEGR
|
23.6m SEK | 0 | -2.4 | -4.2 | -4.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.4B USD | 0.2 | 54.5 | 13.9 | 13.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.1B EUR | 0.3 | 13.3 | 7.8 | 9.9 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.7B USD | 0.3 | 11.9 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.4B EUR | 1.2 | 20.9 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.3B EUR | 1.2 | 23.8 | 9.1 | 16.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.9B USD | 2 | 22.2 | 12.2 | 16.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 25 | 12 | 17.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.2B EUR | 0.6 | 11.5 | 5.4 | 10.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 11.6 | -27.4 | -29.9 | -27.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD | 0.7 | 13.6 | 7.1 | 9.6 |